Milestone Pharmaceuticals has announced the commercial availability of CARDAMYST (etripamil) [...]
The atrial fibrillation (AF) market across the eight major markets [...]
Milestone Pharmaceuticals has announced the commercial availability of CARDAMYST (etripamil) [...]
The atrial fibrillation (AF) market across the eight major markets [...]